LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
NRDY Stock Earnings: Nerdy Beats EPS, Misses Revenue for Q2 2024
NRDY stock results show that Nerdy beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024
PODD stock results show that Insulet missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
DOCS Stock Earnings: Doximity Beats EPS, Beats Revenue for Q1 2025
DOCS stock results show that Doximity beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. More
AKAM Stock Earnings: Akamai Techs Beats EPS, Beats Revenue for Q2 2024
AKAM stock results show that Akamai Techs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024
ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
RCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q2 2024
RCEL stock results show that AVITA Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
